Waypoint Bio is using spatial biology and AI to validate in vivo CAR-T candidates for solid tumors before costly clinical trials.
Waypoint Bio is using spatial biology and AI to validate in vivo CAR-T candidates for solid tumors before costly clinical trials.
大きなシグナルは、AIがデモから予算、規制、安全手順、資本配分へ移りつつあることだ。
参考資料: BusinessWire; BioSpace; Precision Medicine Online; CocoLoop, CocoLoop.